Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
Want to see AMRX full AI Analyst Report?
Kshn001126 150Mg, Kshn001126 300Mg, Kshn001126 600Mg
Healthy Postmenopausal Women
Phase I
Completed
SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal Females
Jun 08, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Amneal Pharmaceuticals Inc (AMRX) have in its pipeline
AMRX is currently developing the following drugs: Crexont Er, Kshn001126 150Mg, Kshn001126 300Mg, Kshn001126 600Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.